V CompBrief BY VELARION

Executive Vice President and Chief Financial Officer · Amgen Inc. (AMGN)

Peter Griffith

FY2025 is the first fiscal year CompBrief holds for Peter Griffith as a named executive officer of Amgen; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$8,610,887

3rd of 5 named executive officers at Amgen by FY2025 total.

5 named officers on file for Amgen, FY2025

See an example →

What this number hides

The filing gives the total. Amgen’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how Amgen’s whole pay program stands against its peers

  • Amgen’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AMGN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 7, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-10.

Free

Get Peter Griffith’s full pay file as a PDF — free

More than this page: up to 10 years of Peter’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Peter Griffith and every company like it: Velarion Intel, free for 3 days, no card →

Peter Griffith compensation by year

Amgen Summary Compensation Table · the one fiscal year held
In US dollars, as Amgen reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$1,223,994
Bonus$0
Stock awards$3,709,745
Option awards$1,589,962
Non-equity incentive$1,652,000
Pension and deferred compensation$0
All other$435,186
Total$8,610,887

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Amgen Inc. DEF 14A filed April 7, 2026, accession 0001193125-26-145588, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Amgen Inc. filed document, accession 0001193125-26-145588. Every figure is read from that document and cited to the page and table it appears in. Filed April 7, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
PSU18,707$6,122,988—
PSU15,750$5,155,133—
PSU12,063$3,948,341—
RSU11,669$3,819,380—
Option10,818—$230.92
Option25,334—$270.44
Option21,608—$235.97
Option20,767—$300.30

Per the Outstanding Equity Awards at Fiscal Year-End table in Amgen Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

6 Form 4 lines since the FY2025 proxy (filed April 7, 2026)
current to 2026-11-10 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-05-07Tax withholding—556$331.1150,150
2026-05-06Tax withholding—502$329.5950,706
2026-05-05Grant or award—3,640$0.0051,208
2026-05-05Grant or award derivative—23,752$329.5923,752
2026-05-02Tax withholding—687$329.8247,568
2026-05-02Tax withholding—746$329.8248,255

The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Amgen’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Robert BradwayChief Executive Officer and President$24,693,120
James BradnerExecutive Vice President, Research and Development$8,639,867
Peter Griffith · this pageExecutive Vice President and Chief Financial Officer$8,610,887
Murdo GordonExecutive Vice President, Global Commercial Operations$8,523,471
David ReeseExecutive Vice President and Chief Technology Officer$8,290,308

Peter Griffith's compensation dossier, Amgen

You have read Peter Griffith's totals and holdings. The dossier adds each equity grant Amgen disclosed for Peter Griffith and Amgen's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full Amgen compensation record

free company brief
Amgen Inc. (AMGN) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within Amgen's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Amgen proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Amgen's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Amgen's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order AMGN

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Peter Griffith's compensation dossier